For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Insulin promotes the absorption of glucose from the blood into skeletal muscle cells, liver, and fat. The production and secretion of glucose by the liver is firmly repressed by extraordinary insulin concentrations in the blood. If the sugar level in the body is more than what is required, insulin plays a major role in storing sugar in the liver. This stored sugar is released when the blood sugar level is low or when the body requires more sugar. Diabetes affects the body's capability to process blood sugar. Gestational diabetes, type 1, and type 2 are three major diabetes types. People living with type 1 diabetes are completely dependent on insulin and have to take artificial insulin on a daily basis. Insulin has to be injected under the skin into the fatty tissue. A wide variety of devices are employed for the supply of insulin, including pens, syringes, injectors, and pumps.
This report elaborates the market size, market characteristics, and market growth of the Insulin Delivery Devices industry, and breaks down according to the type, application, and consumption area of Insulin Delivery Devices. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Insulin Delivery Devices in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Insulin Delivery Devices market covered in Chapter 13:
Ypsomed Holdings AG
F. Hoffmann-La Roche
Insulet
Eli Lilly and Company
Becton Dickinson
Abbott Laboratories
Animas Corporation
B. Braun Melsungen AG
Sanofi
Medtronic, Inc.
Novo Nordisk A/S
In Chapter 6, on the basis of types, the Insulin Delivery Devices market from 2015 to 2025 is primarily split into:
Insulin pumps
Insulin pen
Insulin syringe
Insulin jet
In Chapter 7, on the basis of applications, the Insulin Delivery Devices market from 2015 to 2025 covers:
Diabetes Clinics and Centers
Retail Pharmacy
Hospital Pharmacy
Online Sales
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025